Site Number - 1607 — O'Fallon, Illinois

Site Number - 1607 is a clinical research site located in O'Fallon, Illinois, United States 62269.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site Number - 1607 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Chronic Inflammatory Demyelinating Polyneuropathy.

Sponsors: Immunovant Sciences GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in O'Fallon

Browse all research sites in Illinois · View every site in O'Fallon

• HSHS Medical Group - St. Elizabeth's Hospital
• HSHS St. Elizabeths Hospital
• HSHS St. Elizabeth's Hospital
• HSHS Saint Elizabeth's Hospital
• St. Elizabeth's Hospital
• Hospital Sisters Health System (HSHS) - St Elizabeth's Hospital
• Hospital Sisters Health System Medical
• Cancer Care Center of O'Fallon
• Gateway Clinical Trials
• Research Site
• Novartis Investigative Site
• Cancer Care Specialists of Illinois

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Number - 1607?

Site Number - 1607 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Number - 1607 conducted?

Site Number - 1607 has 1 clinical trials on record, with 1 currently active. Their work covers Chronic Inflammatory Demyelinating Polyneuropathy.

Is Site Number - 1607 accredited by Crixeo Clinical Trials?

Site Number - 1607 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Number - 1607?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.